查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1728281

黄体酮市场－全球产业规模、份额、趋势、机会及预测（按销售管道、最终用途、地区和竞争细分，2020-2030 年）

Progesterone Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球孕酮市场价值为 2.0392 亿美元，预计到 2030 年将达到 2.4258 亿美元，预测期内复合年增长率为 1.89%。孕酮是一种重要的激素，广泛用于荷尔蒙替代疗法 (HRT)、避孕药、生育治疗和兽医应用。它在调节排卵和维持妊娠方面发挥关键作用，这使其在人类和动物健康领域都至关重要。不孕症率的上升和 IVF 等辅助生殖技术 (ART) 的普及，正在推动对孕酮製剂的需求。全球对生殖和更年期健康的认识不断提高也推动了市场成长，尤其是在新兴经济体。然而，市场仍面临着监管复杂性、长期荷尔蒙治疗的潜在副作用以及原材料供应和生产成本波动的挑战。

市场概览
预测期 2026-2030
2024年市场规模 2.0392亿美元
2030年市场规模 2.4258亿美元
2025-2030 年复合年增长率 1.89%
成长最快的领域 直接的
最大的市场 亚太地区

关键市场驱动因素

製药业的成长

主要市场挑战

安全性问题和副作用

主要市场趋势

更年期意识的提高

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球黄体素市场的影响

第五章：全球孕酮市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按销售管道（直接、间接）
    • 依最终用途（荷尔蒙替代疗法、不孕症治疗、月经失调、经前症候群 (PMS)、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美黄体素市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲黄体素市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区孕酮市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美洲孕酮市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东和非洲孕酮市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第 13 章：全球孕酮市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • NAARI PHARMA Pvt. Ltd
  • La Chandra Pharmalab
  • BGP Laboratories Private Limited
  • VM Lifescience
  • Mankind Pharma Ltd
  • Bhugan Lifescience Pvt Ltd
  • Abcures Biosciences LLP
  • Symbiotec Pharmalab
  • Granth Pharma Pvt Ltd
  • Emote Lifesciences LLP

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 29045

The Global Progesterone Market was valued at USD 203.92 million in 2024 and is projected to reach USD 242.58 million by 2030, growing at a CAGR of 1.89% during the forecast period. Progesterone is a vital hormone widely used across hormone replacement therapies (HRT), contraceptives, fertility treatments, and veterinary applications. Its critical role in regulating ovulation and sustaining pregnancy makes it essential in both human and animal health sectors. Increasing infertility rates and expanding access to assisted reproductive technologies (ART), such as IVF, are fueling demand for progesterone-based formulations. Rising global awareness of reproductive and menopausal health is also driving market growth, particularly in emerging economies. However, the market continues to face challenges from regulatory complexities, potential adverse effects of long-term hormone therapy, and fluctuations in raw material supply and production costs.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 203.92 Million
Market Size 2030USD 242.58 Million
CAGR 2025-20301.89%
Fastest Growing SegmentDirect
Largest MarketAsia Pacific

Key Market Drivers

Growth in Pharmaceutical Industry

The expanding focus on women's health, particularly related to menopause, fertility, and hormonal disorders, is a major factor driving demand for progesterone. As more women seek treatment for conditions like perimenopause, endometriosis, and PCOS, progesterone is increasingly used in HRT and therapeutic solutions. Rising age-related hormonal concerns in developed markets with greater healthcare access further support this trend.

In addition, the global burden of infertility is intensifying demand for ART procedures, in which progesterone is commonly administered to support embryo implantation and early pregnancy. With approximately 1 in 6 adults experiencing infertility globally, the need for effective, affordable, and accessible fertility care has grown. Progesterone's integral role in IVF and similar procedures is contributing to its rising use in fertility medications across both developed and developing markets, where awareness and accessibility of such treatments continue to expand.

Key Market Challenges

Safety Concerns and Side Effects

One of the major challenges in the progesterone market is the range of safety concerns and adverse effects associated with its long-term or high-dosage use, especially in HRT and fertility therapies. Common side effects include fatigue, bloating, mood changes, and headaches, while more severe risks such as thromboembolic events, cardiovascular complications, and increased cancer risk-particularly when used alongside estrogen-have raised caution.

In ART procedures, progesterone is essential for luteal phase support, but hormone supplementation may result in conditions like ovarian hyperstimulation syndrome (OHSS) and weight gain, which could deter treatment adherence. These health concerns affect prescription rates and patient trust, posing limitations to widespread adoption despite progesterone's clinical importance in reproductive care.

Key Market Trends

Rise in Menopause Awareness

Growing global awareness about menopause and related hormonal imbalances is shaping demand for effective hormone replacement therapies that include progesterone. With rising life expectancy and an expanding population of women aged 50 and above, the need for symptom management and quality-of-life improvements is increasing. Progesterone, when used with estrogen in HRT, mitigates risks such as endometrial cancer, making it a critical component of balanced therapy.

The trend toward bioidentical hormones, which closely replicate the body's natural hormone structure, is gaining traction. Bioidentical progesterone is increasingly preferred over synthetic alternatives due to its perceived safety and better compatibility with the body, making it a popular choice among women seeking natural options for menopause symptom management. This shift is fueling innovation and driving growth in the global progesterone market.

Key Market Players

  • NAARI PHARMA Pvt. Ltd
  • La Chandra Pharmalab
  • BGP Laboratories Private Limited
  • V M Lifescience
  • Mankind Pharma Ltd
  • Bhugan Lifescience Pvt Ltd
  • Abcures Biosciences LLP
  • Symbiotec Pharmalab
  • Granth Pharma Pvt Ltd
  • Emote Lifesciences LLP

Report Scope

In this report, the Global Progesterone Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Progesterone Market, By Sales Channel:

  • Direct
  • Indirect

Progesterone Market, By End Use:

  • Hormone Replacement Therapy
  • Infertility Treatment
  • Menstrual Disorders
  • Premenstrual Syndrome (PMS)
  • Others

Progesterone Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Progesterone Market.

Available Customizations

Global Progesterone Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Progesterone Market

5. Global Progesterone Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Hormone Replacement Therapy, Infertility Treatment, Menstrual Disorders, Premenstrual Syndrome (PMS), Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Progesterone Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Progesterone Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Progesterone Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Progesterone Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Progesterone Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Progesterone Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Progesterone Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Progesterone Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Progesterone Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Progesterone Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Progesterone Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Progesterone Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Progesterone Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Progesterone Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Progesterone Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Progesterone Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Progesterone Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Progesterone Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Progesterone Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Progesterone Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Progesterone Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Progesterone Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Progesterone Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Progesterone Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Progesterone Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. NAARI PHARMA Pvt. Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. La Chandra Pharmalab
  • 15.3. BGP Laboratories Private Limited
  • 15.4. V M Lifescience
  • 15.5. Mankind Pharma Ltd
  • 15.6. Bhugan Lifescience Pvt Ltd
  • 15.7. Abcures Biosciences LLP
  • 15.8. Symbiotec Pharmalab
  • 15.9. Granth Pharma Pvt Ltd
  • 15.10. Emote Lifesciences LLP

16. Strategic Recommendations

17. About Us & Disclaimer